First Trial in New NCI-Zenith Partnership Will Test ZEN-3694 Combo for Resistant OC
News
The first clinical trial resulting from a new Zenith Epigenetic collaboration with the National Cancer Institute (NCI) will soon test a combination of the investigational therapy ZEN-3694 plus the immune ... Read more